دورية أكاديمية
Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule.
| العنوان: | Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule. |
|---|---|
| المؤلفون: | Koziolek M; Department of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Straße 3, 17489 Greifswald, Germany., Grimm M; Department of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Straße 3, 17489 Greifswald, Germany., Bollmann T; Department of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Straße 3, 17489 Greifswald, Germany., Schäfer KJ; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Blattner SM; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Lotz R; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Boeck G; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Weitschies W; Department of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Straße 3, 17489 Greifswald, Germany. Electronic address: werner.weitschies@uni-greifswald.de. |
| المصدر: | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2019 Mar; Vol. 136, pp. 221-230. Date of Electronic Publication: 2019 Jan 28. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3441 (Electronic) Linking ISSN: 09396411 NLM ISO Abbreviation: Eur J Pharm Biopharm Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Amsterdam : Elsevier Science Original Publication: Stuttgart : Wissenschaftliche Verlagsgesellschaft, c1991- |
| مواضيع طبية MeSH: | Gastrointestinal Absorption/*physiology , Gastrointestinal Transit/*physiology , Pentagastrin/*administration & dosage , Telemetry/*methods, Administration, Oral ; Animals ; Capsules ; Cross-Over Studies ; Dogs ; Female ; Gastrointestinal Absorption/drug effects ; Gastrointestinal Transit/drug effects ; Humans ; Male ; Pentagastrin/pharmacokinetics ; Telemetry/instrumentation |
| مستخلص: | In preclinical research, Beagle dogs are an important model for formulation development and for evaluation of food effects on drug absorption. In this study, the gastrointestinal transit conditions in Beagle dogs were studied with a telemetric motility capsule at different intake conditions. In a cross-over study design, the SmartPill® was given to six Beagle dogs to measure transit times, pH values, pressures and temperatures in the different parts of the canine GI tract. Moreover, the effects of commonly applied pre-treatments as with pentagastrin and famotidine on GI transit conditions were investigated. The gastric transit time in fasted state was short (0.57 ± 0.37 h) and only slightly affected by the pre-treatments. In fed state, gastric transit was clearly prolonged (2.94 ± 0.91 h). The mean intestinal transit time was in the range of 1-2 h and not affected by the intake conditions. The gastric pH values in fasted and fed Beagle dogs were highly variable, but pre-treatment with pentagastrin and famotidine clearly decreased variability. Pre-treatment with pentagastrin resulted in minimum pH values around 0.5 pH units lower than without pre-treatment. Oral administration of famotidine led to constantly elevated pH values of pH 7-8. The maximum pressures in the canine GI tract did not vary significantly between the study arms and typically, maximum pressures of up to 800 mbar were observed in the stomach. The comparison of the data from this study with recent SmartPill® data from humans revealed that major differences could be observed with respect to gastric transit times in fed state, small intestinal transit times as well as maximum pressures arising during GI transit. These differences should be kept in mind if the dog model is used to assess the in vivo performance of solid oral dosage forms intended for use in humans. (Copyright © 2019 Elsevier B.V. All rights reserved.) |
| فهرسة مساهمة: | Keywords: Animal model; Beagle dog; Food effect; Gastrointestinal transit; Luminal pH; Oral biopharmaceutics; Preclinical species; Wireless motility capsule; pH dependent absorption |
| المشرفين على المادة: | 0 (Capsules) EF0NX91490 (Pentagastrin) |
| تواريخ الأحداث: | Date Created: 20190201 Date Completed: 20190530 Latest Revision: 20190530 |
| رمز التحديث: | 20240628 |
| DOI: | 10.1016/j.ejpb.2019.01.026 |
| PMID: | 30703546 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!